Skip to main content
SpringerLink
Log in

Uptake of FITC-Chitosan Nanoparticles by A549 Cells

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The objective of this study was to evaluate the extent and mechanism of uptake of fluorescent chitosan nanoparticles by the A549 cells, a human cell line derived from the respiratory epithelium.

Methods. Covalent conjugation with fluorescein-5-isothiocyanate yielded stably labeled chitosan molecules, which were successfully formulated into nanoparticles by ionotropic gelation. Uptake of fluorescein-5-isothiocyanate-chitosan nanoparticles and chitosan molecules by confluent A549 cells was quantified by fluorometry.

Results. Cellular uptake of chitosan nanoparticles was concentration and temperature dependent, having Km and Vmax of 3.84 μM and 58.14 μg/mg protein/h, respectively. Uptake of chitosan nanoparticles was up to 1.8-fold higher than that of chitosan molecules alone and was not inhibited by excess unlabeled chitosan molecules. Hyperosmolarity, chlorpromazine and K+ depletion inhibited by 65, 34, and 54%, respectively, the uptake of chitosan nanoparticles at 37°C, but filipin had no influence on the uptake. Confocal imaging confirmed the internalization of the chitosan nanoparticles by the A549 cells at 37°C.

Conclusions. Formulation of chitosan into nanoparticles significantly improved its uptake by the A549 cells. Internalization of chitosan nanoparticles by the cells seems to occur predominantly by adsorptive endocytosis initiated by nonspecific interactions between nanoparticles and cell membranes, and was in part mediated by clathrin-mediated process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. N. G. M. Schipper, S. Olsson, J. A. Hoogstraate, A. G. deBoer, K. M. Vårum, and P. Artursson. Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm.Res. 14:923-929 (1997).

    Google Scholar 

  2. N. G. M. Schipper, K. M. Vårum, P. Stenberg, G. Ocklind, H. Lennernäs, and P. Artursson. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. Eur.J.Pharm.Sci. 8:335-343 (1999).

    Google Scholar 

  3. A. F. Kotzé, H. L. Lueβen, A. G. deBoer, J. C. Verhoef, and H. E. Junginger. Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environments. Eur.J.Pharm.Sci. 7:145-151 (1998).

    Google Scholar 

  4. H.-Q. Mao, K. Roy, V. L. Troung-Le, and K. A. Janes, K. Y. Lin, Y. Wang, J. T. August, and K. W. Leong. Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency. J.Control.Release 70:399-421 (2001).

    Google Scholar 

  5. L. Illum, I. Jabbal-Gill, M. Hinchcliffe, A. N. Fisher, and S. S. Davis. Chitosan as a novel nasal delivery system for vaccines. Adv.Drug Deliv.Rev. 51:81-96 (2001).

    Google Scholar 

  6. K. A. Janes, M. P. Fresneau, A. Marazuela, A. Fabra, and M. J. Alonso. Chitosan nanoparticles as delivery systems for doxorubicin. J.Control.Release 73:255-267 (2001).

    Google Scholar 

  7. T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, J. X. Xiao, and T. Kissel. Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake? Eur.J.Pharm.Biopharm. 50:147-160 (2000).

    Google Scholar 

  8. F. Delie. Evaluation of nano-and microparticle uptake by the gastrointestinal tract. Adv.Drug Deliv.Rev. 34:221-223 (1998).

    Google Scholar 

  9. K. Suh, B. Jeong, F. Liu, and S. W. Kim. Cellular uptake study of biodegradable nanoparticles in muscular smooth cells. Pharm.Res. 12:1495-1498 (1998).

    Google Scholar 

  10. B. Q. Roula and M. A. Mansoor. Synthesis of a fluorescent chitosan derivative and its application for the study of chitosanmucin interactions. Carbohydr.Polym. 38:99-107 (1999).

    Google Scholar 

  11. O. Hiraku and M. Yoshiharu. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20:175-182 (1999).

    Google Scholar 

  12. W. Wang, S. Q. Bo, S. Q. Li, and W. Qin. Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. Int.J.Biol.Macromol. 13:281-285 (1991).

    Google Scholar 

  13. S. C. Tan, E. Khor, T. K. Tan, and S. M. Wong. The degree of deacetylation of chitosan: Advocating the first derivative UV-spectrophotometry method of determination. Talanta 45:713-719 (1998).

    Google Scholar 

  14. P. Calvo, C. Remuñán-Lòpez, J. L. Vila-Jato, and M. J. Alonso. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J.Appl.Polymer Sci. 63:125-132 (1997).

    Google Scholar 

  15. W. Lutz and R. Kumar. Hypertonic sucrose treatment enhances second messenger accumulation in vasopressin-sensitive cells. Am.J.Physiol. 264:F228-F233 (1993).

    Google Scholar 

  16. G. G. Pietra, L. Johns, W. Byrnes, and S. Villaschi. Inhibition of adsorptive endocytosis and transcytosis in pulmonary microvessels. Lab.Invest. 59:683-690 (1988).

    Google Scholar 

  17. R. Miñana, J. M. Duran, M. Tomas, J. Renau-Piqueras, and C. Guerri. Neural cell adhesion molecule is endocytosed via a clathrin-dependent pathway. Eur.J.Neurosci. 13:749-756 (2001).

    Google Scholar 

  18. I. H. Madshus, K. Sandvig, S. Olsnes, and B. V. Deurs. Effect of reduced endocytosis induced by hypotonic shock and potassium depletion on the infection of Hep 2 cells by picornaviruses. J.Cell Physiol. 131:14-22 (1987).

    Google Scholar 

  19. G. Daukas and S. H. Zigmond. Inhibition of receptor-mediated but not fluid-phase endocytosis in polymorphonuclear leukocytes. J.Cell Biol. 101:1673-1679 (1985).

    Google Scholar 

  20. P. A. Orlandi and P. H. Fishman. Filipin-dependent inhibition of cholera toxin: Evidence for toxin internalization and activation through caveolae-like domains. J.Cell Biol. 141:905-915 (1998).

    Google Scholar 

  21. C. M. Lehr. The transcytosis approach. In A.G. de Boer (ed.), Drug Absorption Enhancement-Concepts, Possibilities, Limitations and Trends, Harwood Academic, Switzerland, 1994, pp. 325-366.

    Google Scholar 

  22. B. J. Nichols and J. Lippincott-Schwartz. Endocytosis without clathrin coats. Trends Cell Biol. 11:406-412 (2001).

    Google Scholar 

  23. J. E. Schnitzer. Caveolae: From basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv.Drug Deliv.Rev 49:265-280 (2001).

    Google Scholar 

  24. L. H. Wang, K. G. Rothberg, and R. G. Anderson. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J.Cell Biol. 123:1107-1117 (1993).

    Google Scholar 

  25. C. Racine, M. Belanger, H. Hirabayashi, M. Boucher, J. Chakir, and J. Couet. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem.Biophys.Res.Commun. 255:580-586 (1999).

    Google Scholar 

  26. N. G. M. Schipper. K. M Vårum and P. Artursson. Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm.Res. 13:1686-1692 (1996).

    Google Scholar 

  27. L. Illum, N. F. Farraj, and S. S. Davis. Chitosan as a novel nasal delivery system for peptide drugs. Pharm.Res. 11:1186-1189 (1994).

    Google Scholar 

  28. N. Haffejee, J. Du Plessis, D. G. Muller, C. Schultz, A. F. Kotze, and C. Goosen. Intranasal toxicity of selected absorption enhancers. Pharmazie 56:882-888 (2001).

    Google Scholar 

  29. J. A. Swanson and C. Watts. Macropinocytosis. Trends Cell Biol. 5:424-428 (1995).

    Google Scholar 

  30. R. C. Stearns, J. D. Paulauskis, and J. J. Godleski. Endocytosis of ultrafine particles by A549 cells. Am.J.Respir.Cell Mol.Biol. 24:108-115 (2001).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore, 117543

    Min Huang, Zengshuan Ma & Lee-Yong Lim

  2. Department of Chemistry, National University of Singapore, 18 Science Drive 4, Singapore, 117543

    Eugene Khor

Authors
  1. Min Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zengshuan Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugene Khor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lee-Yong Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lee-Yong Lim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, M., Ma, Z., Khor, E. et al. Uptake of FITC-Chitosan Nanoparticles by A549 Cells. Pharm Res 19, 1488–1494 (2002). https://doi.org/10.1023/A:1020404615898

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020404615898

Search

Navigation